PURE Bioscience PURE Stock
PURE Bioscience Price Chart
PURE Bioscience PURE Financial and Trading Overview
| PURE Bioscience stock price | 0.06 USD |
| Previous Close | 0.08 USD |
| Open | 0.08 USD |
| Bid | 0.07 USD x 2000000 |
| Ask | 0.07 USD x 1000000 |
| Day's Range | 0.07 - 0.08 USD |
| 52 Week Range | 0.04 - 0.14 USD |
| Volume | 10.9K USD |
| Avg. Volume | 41.52K USD |
| Market Cap | 9.1M USD |
| Beta (5Y Monthly) | 0.106 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PURE Valuation Measures
| Enterprise Value | 13.78M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 1.03 |
| Price/Sales (ttm) | 3.7811508 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 5.725 |
| Enterprise Value/EBITDA | -6.963 |
Trading Information
PURE Bioscience Stock Price History
| Beta (5Y Monthly) | 0.106 |
| 52-Week Change | -30.00000000000000000000000000000000% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.14 USD |
| 52 Week Low | 0.04 USD |
| 50-Day Moving Average | 0.08 USD |
| 200-Day Moving Average | 0.07 USD |
PURE Share Statistics
| Avg. Volume (3 month) | 41.52K USD |
| Avg. Daily Volume (10-Days) | 45.86K USD |
| Shares Outstanding | 130.02M |
| Float | 72.16M |
| Short Ratio | 2.56 |
| % Held by Insiders | 41.25% |
| % Held by Institutions | 0% |
| Shares Short | 222.97K |
| Short % of Float | 1.85% |
| Short % of Shares Outstanding | 1.82% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | July 31, 2025 |
| Most Recent Quarter (mrq) | January 31, 2026 |
| Next Fiscal Year End | July 31, 2026 |
Profitability
| Profit Margin | -89.77% |
| Operating Margin (ttm) | -153.82% |
| Gross Margin | 59.78% |
| EBITDA Margin | -82.21% |
Management Effectiveness
| Return on Assets (ttm) | -181.90% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.41M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | 13.60% |
| Gross Profit (ttm) | 1.44M USD |
| EBITDA | -1979000 USD |
| Net Income Avi to Common (ttm) | -2161000 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 198K USD |
| Total Cash Per Share (mrq) | 0.002 USD |
| Total Debt (mrq) | 6.15M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.255 |
| Book Value Per Share (mrq) | -0.056 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1824000 USD |
| Levered Free Cash Flow (ttm) | -1478000 USD |
Profile of PURE Bioscience
| Country | United States |
| State | CA |
| City | El Cajon |
| Address | 771 Jamacha Rd., #512 |
| ZIP | 92019 |
| Phone | 619 596 8600 |
| Website | https://www.purebio.com |
| Industry | Household & Personal Products |
| Sector(s) | Consumer Defensive |
| Full Time Employees | 11 |
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company's technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products. The company serves food processing, food service and hospitality, healthcare, facility care, transportation, and personal care industries. It sells its products through end-use customers and third-party distributors. The company was incorporated in 1992 and is based in El Cajon, California.
Q&A For PURE Bioscience Stock
What is a current PURE stock price?
PURE Bioscience PURE stock price today per share is 0.06 USD.
How to purchase PURE Bioscience stock?
You can buy PURE shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PURE Bioscience?
The stock symbol or ticker of PURE Bioscience is PURE.
Which industry does the PURE Bioscience company belong to?
The PURE Bioscience industry is Household & Personal Products.
How many shares does PURE Bioscience have in circulation?
The max supply of PURE Bioscience shares is 130.02M.
What is PURE Bioscience Price to Earnings Ratio (PE Ratio)?
PURE Bioscience PE Ratio is now.
What was PURE Bioscience earnings per share over the trailing 12 months (TTM)?
PURE Bioscience EPS is -0.02 USD over the trailing 12 months.
Which sector does the PURE Bioscience company belong to?
The PURE Bioscience sector is Consumer Defensive.


